Results 201 to 210 of about 70,987 (344)

Cytotoxic Profiling of 3′,4′,5′‐Trimethoxychalcones Reveals Cell‐Line‐Dependent Cytotoxic Activity: An In Vitro and In Silico Study

open access: yesChemistry &Biodiversity, Volume 23, Issue 5, May 2026.
A systematic evaluation of 3′,4′,5′‐trimethoxychalcones reveals potent yet strongly cell‐line‐dependent cytotoxic activity across multiple cancer models. Despite high potency, no universal structure–activity relationships emerge. Combined in vitro and in silico analyses indicate a multifactorial, context‐dependent mode of action, underscoring the need ...
Aleksandar Y. Mehandzhiyski   +5 more
wiley   +1 more source

Nonmass‐Forming Type Anocanal Cancer With Pagetoid Spread With a Challenging Differential Diagnosis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Pagetoid spread (PS) of anorectal cancer is relatively rare and is associated with poor prognosis compared with Extramammary Paget disease. It is therefore essential to accurately differentiate between the two entities. In PS cases, the primary tumor lesion is usually obvious; however, this is not the case in nonmass‐forming type anorectal ...
Mizunori Yaegashi   +3 more
wiley   +1 more source

Identify the PANoptosis signature and prognostic model via a multimachine-learning computational framework for bladder urothelial carcinoma. [PDF]

open access: yesCancer Cell Int
Xin S   +14 more
europepmc   +1 more source

Periocular Pigmentation After Gemcitabine Monotherapy for Bladder Cancer: A Rare Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT A patient with advanced bladder cancer received antitumor therapy consisting of gemcitabine on days 1 and 8 combined with cisplatin and treliprimab on day 1. Severe periorbital hyperpigmentation occurred 30 min after gemcitabine infusion on day 8. Symmetrical diffuse hyperpigmentation of a dark brown hue with indistinct borders appeared around
Li Juan, Chen Weiping
wiley   +1 more source

Home - About - Disclaimer - Privacy